Drugs / simiaowan
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04069325 | Sep 2019 → Jul 2020 | gout | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | simiaowan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04069325 ↗ |
| Route | Oral | “oral simiaowan at standard clinical doses (6g twice daily)” NCT04069325 ↗ |